157 related articles for article (PubMed ID: 36572673)
1. Loss of tumor suppressor WWOX accelerates pancreatic cancer development through promotion of TGFβ/BMP2 signaling.
Husanie H; Abu-Remaileh M; Maroun K; Abu-Tair L; Safadi H; Atlan K; Golan T; Aqeilan RI
Cell Death Dis; 2022 Dec; 13(12):1074. PubMed ID: 36572673
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.
Kuroki T; Yendamuri S; Trapasso F; Matsuyama A; Aqeilan RI; Alder H; Rattan S; Cesari R; Nolli ML; Williams NN; Mori M; Kanematsu T; Croce CM
Clin Cancer Res; 2004 Apr; 10(7):2459-65. PubMed ID: 15073125
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic tumor suppressor functions of WWOX antagonize metastasis.
Khawaled S; Nigita G; Distefano R; Oster S; Suh SS; Smith Y; Khalaileh A; Peng Y; Croce CM; Geiger T; Seewaldt VL; Aqeilan RI
Signal Transduct Target Ther; 2020 Apr; 5(1):43. PubMed ID: 32300104
[TBL] [Abstract][Full Text] [Related]
4. WWOX: a fragile tumor suppressor.
Schrock MS; Huebner K
Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
[TBL] [Abstract][Full Text] [Related]
5. WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
Aldaz CM; Ferguson BW; Abba MC
Biochim Biophys Acta; 2014 Aug; 1846(1):188-200. PubMed ID: 24932569
[TBL] [Abstract][Full Text] [Related]
6. Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells.
Nakayama S; Semba S; Maeda N; Aqeilan RI; Huebner K; Yokozaki H
Cancer Sci; 2008 Jul; 99(7):1370-6. PubMed ID: 18460020
[TBL] [Abstract][Full Text] [Related]
7. Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer.
Abdeen SK; Ben-David U; Shweiki A; Maly B; Aqeilan RI
Cell Death Dis; 2018 Aug; 9(8):832. PubMed ID: 30082886
[TBL] [Abstract][Full Text] [Related]
8. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding.
Ferguson BW; Gao X; Zelazowski MJ; Lee J; Jeter CR; Abba MC; Aldaz CM
BMC Cancer; 2013 Dec; 13():593. PubMed ID: 24330518
[TBL] [Abstract][Full Text] [Related]
9. WWOX, a new potential tumor suppressor gene.
Hezova R; Ehrmann J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):11-5. PubMed ID: 17690733
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of Wwox reveals a tumor suppressor function.
Aqeilan RI; Trapasso F; Hussain S; Costinean S; Marshall D; Pekarsky Y; Hagan JP; Zanesi N; Kaou M; Stein GS; Lian JB; Croce CM
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3949-54. PubMed ID: 17360458
[TBL] [Abstract][Full Text] [Related]
11. Loss of fragile WWOX gene leads to senescence escape and genome instability.
Cheng HC; Huang PH; Lai FJ; Jan MS; Chen YL; Chen SY; Chen WL; Hsu CK; Huang W; Hsu LJ
Cell Mol Life Sci; 2023 Oct; 80(11):338. PubMed ID: 37897534
[TBL] [Abstract][Full Text] [Related]
12. Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.
Abdeen SK; Del Mare S; Hussain S; Abu-Remaileh M; Salah Z; Hagan J; Rawahneh M; Pu XA; Russell S; Stein JL; Stein GS; Lian JB; Aqeilan RI
J Cell Physiol; 2013 Jul; 228(7):1377-82. PubMed ID: 23254685
[TBL] [Abstract][Full Text] [Related]
13. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
[TBL] [Abstract][Full Text] [Related]
14. WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.
Abu-Odeh M; Salah Z; Herbel C; Hofmann TG; Aqeilan RI
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4716-25. PubMed ID: 25331887
[TBL] [Abstract][Full Text] [Related]
15. The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability.
Aqeilan RI; Abu-Remaileh M; Abu-Odeh M
Cell Mol Life Sci; 2014 Dec; 71(23):4589-99. PubMed ID: 25245215
[TBL] [Abstract][Full Text] [Related]
16. RHBDD2‑WWOX protein interaction during proliferative and differentiated stages in normal and breast cancer cells.
Ferretti VA; Canzoneri R; Palma S; Lacunza E; Aldaz CM; Abba MC
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109992
[TBL] [Abstract][Full Text] [Related]
17. WWOX: its genomics, partners, and functions.
Del Mare S; Salah Z; Aqeilan RI
J Cell Biochem; 2009 Nov; 108(4):737-45. PubMed ID: 19708029
[TBL] [Abstract][Full Text] [Related]
18. WW domain-containing oxidoreductase in neuronal injury and neurological diseases.
Chang HT; Liu CC; Chen ST; Yap YV; Chang NS; Sze CI
Oncotarget; 2014 Dec; 5(23):11792-9. PubMed ID: 25537520
[TBL] [Abstract][Full Text] [Related]
19. Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations.
Maeda N; Semba S; Nakayama S; Yanagihara K; Yokozaki H
Virchows Arch; 2010 Oct; 457(4):423-32. PubMed ID: 20737170
[TBL] [Abstract][Full Text] [Related]
20. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
